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Precise timing of transcription by c-di-GMP
coordinates cell cycle and morphogenesis
in Caulobacter
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Badri N. Dubey 2, Jutta Nesper1, Tilman Schirmer 2, Sebastian Hiller 2 & Urs Jenal 1*
Bacteria adapt their growth rate to their metabolic status and environmental conditions by
modulating the length of their G1 period. Here we demonstrate that a gradual increase in the
concentration of the second messenger c-di-GMP determines precise gene expression during
G1/S transition in Caulobacter crescentus. We show that c-di-GMP stimulates the kinase ShkA
by binding to its central pseudo-receiver domain, activates the TacA transcription factor, and
initiates a G1/S-specific transcription program leading to cell morphogenesis and S-phase
entry. Activation of the ShkA-dependent genetic program causes c-di-GMP to reach peak
levels, which triggers S-phase entry and promotes proteolysis of ShkA and TacA. Thus, a
gradual increase of c-di-GMP results in precise control of ShkA-TacA activity, enabling G1/S-
specific gene expression that coordinates cell cycle and morphogenesis.
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The bacterial cell cycle is divided into three periods: after celldivision and before initiation of chromosome replication(B or G1); chromosome replication (C or S); and cell
division (D or G2)1. Since chromosome replication and cell
division (C and D periods) remain constant over a wide range of
growth rates2,3, the step committing cells to initiate chromosome
replication largely determines bacterial proliferation rates. Bac-
teria like Escherichia coli or Bacillus subtilis can increase their
growth rate by bypassing the B period and by initiating replica-
tion multiple times per division cycle2. In contrast, Caulobacter
crescentus strictly separates its cell cycle stages. An asymmetric
division generates a sessile stalked (ST) cell, which directly
reenters S-phase, and a motile swarmer (SW) cell that remains in
G1 for a variable time depending on nutrient availability4,5.
Coincident with G1/S transition, motile SW cells undergo mor-
phogenesis to gain sessility (Fig. 1a). But what determines the
length of G1 in this organism has remained unclear.
In C. crescentus, replication initiation is regulated by the cell
cycle kinase CckA. CckA is a bifunctional enzyme that acts as a
kinase for the replication initiation inhibitor CtrA in G1, but
switches to being a phosphatase in S phase, resulting in the
inactivation of CtrA and clearance of the replication block6
(Fig. 1a). The CckA switch is governed by two response reg-
ulators, DivK and PleD. While DivK controls CckA activity
through protein–protein interactions7–9, PleD is a diguanylate
cyclase, which is responsible for the characteristic oscillation of c-
di-GMP during the cell cycle10. The concentration of c-di-GMP,
below the detection limit in G1, increases during G1/S to reach
peak levels at the onset of S-phase11 where it allosterically sti-
mulates CckA phosphatase9 (Fig. 1a).
Activation of DivK and PleD is directed by the SpmX scaf-
folding protein, which accumulates during G1/S and recruits
DivJ, the kinase of DivK and PleD, to the incipient stalked cell
pole (Fig. 1a)12. This makes SpmX accumulation the earliest
known event to trigger S-phase entry. However, it is unclear how
spmX expression is timed during G1/S to initiate replication.
Transcription of spmX is regulated by the response regulator
TacA, which in its phosphorylated form also induces the
expression of a large set of genes required for SW-to-ST cell
morphogenesis12,13. TacA is activated via a multistep phosphor-
ylation cascade (Fig. 1b) consisting of the sensor histidine kinase
ShkA, and the phosphotransferase protein ShpA12,13. ShkA is a
multidomain protein kinase with a catalytic domain (CA) that
binds ATP and transfers a phosphate via the conserved His
residue of the dimerization histidine-phosphotransfer domain
(DHp) to a conserved Asp residue of the C-terminal receiver
domain (REC2)12,13 (Fig. 1b). TacA controls a large set of target
genes including staR, which encodes a transcription factor
important for stalk elongation. Thus, this phosphorelay system
coordinates replication initiation with morphogenesis. In accor-
dance, cells lacking TacA are elongated, stalk-less and show
altered DNA profiles compared with wild type13,14. However, the
signal activating ShkA has remained unknown (Fig. 1b).
Here we demonstrate that an upshift in levels of the second
messenger c-di-GMP determines precise gene expression during
G1/S. A combination of genetic, biochemical and cell biology data
revealed that c-di-GMP controls the ShkA-TacA pathway by
directly binding to the ShkA sensor histidine kinase and strongly
stimulating its kinase activity. We demonstrate that binding of c-
di-GMP to a pseudo-receiver domain of ShkA abrogates ShkA
auto-inhibition leading to the activation of the ShkA-TacA
pathway. C-di-GMP-mediated activation of ShkA and the sub-
sequent c-di-GMP-mediated proteolysis of ShkA together define
a window of ShkA activity during the cell cycle. This window is
sharpened to a narrow, G1/S-specific period by TacA degrada-
tion, which precedes the degradation of ShkA. Thus, the exact
timing of G1/S-specific gene expression results from the con-
secutive c-di-GMP-mediated activation and degradation of ShkA-
TacA phosphorylation components.
Results
C-di-GMP stimulates ShkA kinase activity in vivo and in vitro.
A C. crescentus strain lacking all diguanylate cyclases (cdG0
strain), which was generated to remove all traces of the second
messenger c-di-GMP, shows strong developmental and mor-
phological abnormalities with mutant cells being irregularly
shaped, elongated and lacking all polar appendages11. Because
stalk biogenesis depends on an active ShkA-TacA phosphorelay
(Fig. 1b)13, we tested if c-di-GMP controls the ShkA-TacA
pathway. Expression of TacAD54E, a phospho-mimetic form of
TacA13, restored stalk biogenesis, transcription of the TacA tar-
gets staR and spmX, as well as localization of a SpmX-mCherry
fusion to the stalked pole (Fig. 1c, d; Supplementary Fig. 1). spmX
and staR transcription was also restored when c-di-GMP was
reintroduced by expression of the heterologous diguanylate
cyclase (DGC) dgcZ from E. coli in the cdG0 background or in a
strain that lacks all DGCs and phosphodiesterases (PDE) (rcdG0
strain) (Fig. 1d; Supplementary Fig. 1). Phos-tag PAGE analysis
revealed that TacA and ShkA were unphosphorylated in the cdG0
strain. This phosphorylation was restored upon expression of the
constitutively active DGC PleD*15 (Fig. 1e). In contrast, expres-
sion of the heterologous phosphodiesterase PA5295 from Pseu-
domonas aeruginosa, which also lowers c-di-GMP levels, in wild-
type cells reduced TacA and ShkA phosphorylation (Fig. 1f). Stalk
formation is independent of the ShkA-TacA pathway when cells
are grown in a low-phosphate medium9. In agreement with this, a
strain lacking c-di-GMP formed stalks at low-phosphate con-
centrations, but failed to localize DivJ (Supplementary Fig. 1).
Many cells displayed bipolar stalks, indicating that at low-
phosphate c-di-GMP controls stalk positioning through a path-
way distinct from ShkA-TacA. Altogether, these results indicate
that c-di-GMP acts upstream of and is required for the activity of
the ShkA-TacA phosphorelay.
In vitro phosphorylation assays with purified ShkA or with all
components of the phosphorelay demonstrated that c-di-GMP
strongly and specifically stimulates ShkA autokinase activity
(Fig. 1g, h; Supplementary Fig. 2a). Moreover, purified ShkA
bound c-di-GMP with a KD in the sub-micromolar range
(Supplementary Fig. 2b). Altogether, we conclude that c-di-
GMP activates the ShkA-TacA pathway by directly binding to
and allosterically stimulating ShkA kinase.
C-di-GMP activates ShkA by binding to its pseudo-receiver
domain. We next sought to dissect the mechanism of c-di-GMP-
mediated ShkA activation. We devised a genetic selection (see
“Methods”) to isolate shkA mutations that restored spmX
expression in a rcdG0 background. Independent mutations were
identified in two residues (D369, R371) within a short stretch of
three highly conserved amino acids in the linker region between
REC1 and REC2 (hereafter referred to as the “DDR” motif)
(Fig. 2a; Supplementary Fig. 3). These results identified the REC1-
REC2 linker region as a critical determinant of ShkA activation.
We further characterized the D369N variant both in a wild-type
background and in a strain expressing a stabilized version of TacA
(TacADD), and confirmed that TacA phosphorylation levels and
spmX transcription were restored to wild-type levels in the rcdG0
background harboring the shkAD369N allele (Fig. 2b, c). Also,
purified ShkAD369N protein showed strong autophosphorylation
activity even in the absence of c-di-GMP (Fig. 2d). The mutant
retained its ability to bind c-di-GMP in vitro (Supplementary
Fig. 2c) and could still be partially stimulated by c-di-GMP
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Fig. 1 C-di-GMP controls the ShkA-TacA phosphorelay in C. crescentus. a Schematic of the C. crescentus cell cycle with swarmer and stalked cells colored
in blue and orange, respectively, and the G1- and S-phases of the cell cycle indicated in similar colors. Stage-specific kinase (Kin) and phosphatase (Pho)
activities of CckA are indicated with the coloring referring to stage-related activities. DivK and PleD that control the CckA switch are highlighted.
b Schematic of the ShkA-ShpA-TacA phosphorelay. c Quantification of cells with stalks and SpmX-mCherry foci of strains expressing a chromosomal
spmX-mCherry fusion and plasmid-driven tacA, tacAD54E, or dgcZ. EV, empty vector. The number of cells analyzed (N) is indicated above the graph. Also see
Supplementary Fig. 1. d spmX promoter activity (plasmid pRKlac290-spmX) in indicated strains. IPTG indicates induction of dgcZ expression. Shown are
mean values and standard deviations (N≥ 2). e Phos-tag PAGE immunoblots of strains producing 3xFLAG-tagged ShkA or TacA from the native loci and
expressing plasmid-borne PleD*. Relative phosphorylation (rel. phos.) of TacA and ShkA were determined by calculating the ratio of intensities of
phosphorylated and unphosphorylated bands normalized to this value of the wild type with empty vector control. f Phos-tag PAGE immunoblots of strains
encoding 3xFLAG-tagged ShkA or TacA at the native loci or the respective mutant alleles encoding degradation-resistant variants TacADD or ShkADD.
Strains carried a plasmid for cumate-inducible expression of wild type or a catalytic mutant (AAL) of the phosphodiesterase (PDE) PA5295. Samples were
harvested after addition cumate as indicated. PA5295AAL samples were harvested 4 h post induction. Relative phosphorylation (rel. phos.) was normalized
to the PA5295AAL control. g In vitro phosphorylation of purified ShkA with different nucleotides present (1 mM, 100 μM, 10 μM). Positive (+) and negative
(−) controls contained 100 μM c-di-GMP and ddH2O, respectively. Reactions were initiated by addition of 500 μM radiolabeled ATP and allowed to
proceed for 15min at room temperature. h In vitro phosphorylation assays with purified components (4 μM) of the ShkA-ShpA-TacA phosphorelay with
(+) or without (−) c-di-GMP (76 μM). Reactions were initiated as described for g. Source data are provided as a Source Data file.
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both in vivo (Fig. 2b) and in vitro (Supplementary Fig. 2d).
Thus, mutations in the DDR motif uncouple ShkA activity from
c-di-GMP without interfering with c-di-GMP binding.
We used the c-di-GMP independence of the D369N ShkA
variant to identify residues involved in c-di-GMP binding. We
reasoned that mutations in ShkA specifically interfering with c-
di-GMP-mediated activation should be rescued when combined
with D369N. In contrast, mutants causing more general kinase
defects (ATP-binding, phosphotransfer, protein stability etc.)
would not be recuperated when combined with D369N. An
alignment of ShkA orthologs from C. crescentus and related
organisms revealed a total of 25 candidate residues for c-di-GMP
binding distributed throughout the entire protein (Supplementary
Fig. 3). Of all the mutants that severely affected ShkA activity
(Supplementary Fig. 4a, b) and that were rescued in vivo (Fig. 2e)
and in vitro (Fig. 2f) when combined with D369N, only one,
Y338A, in REC1, interfered with c-di-GMP binding (Fig. 2g, h),
while the other mutations likely affect c-di-GMP-mediated
conformational changes required for activation.
Thus, Y338 in REC1 is likely a part of the c-di-GMP binding
site. Indeed, the purified REC1 domain alone was able to bind c-
di-GMP, although with lower affinity than full-length ShkA
(Fig. 2i). NMR spectroscopy with REC1 revealed a fold
reminiscent of prototypical REC domains, except that helix α3 is
not present irrespective of the presence or absence of c-di-GMP
(Supplementary Fig. 4c–f). Upon the addition of c-di-GMP,
REC1 shows chemical shift perturbations (CSPs), which cluster on
the β5-α5 surface (Fig. 2j; Supplementary Fig. 4g). Importantly,
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these residues include Y338 and are well conserved (Fig. 2k;
Supplementary Fig. 3). Some of the other residues implicated in c-
di-GMP binding by NMR were also important for ShkA activity
in vivo (Supplementary Fig. 4h). Altogether, these experiments
revealed a REC1 pseudo-receiver domain of ShkA as the primary
docking site for c-di-GMP, and identified residues directly
involved in c-di-GMP binding and c-di-GMP-mediated activation
of ShkA. In silico analysis revealed that pseudo-receiver domains,
although often not annotated, are widespread among histidine
kinases (Supplementary Fig. 5, Supplementary Data 1). We
propose that pseudo-receiver domains have lost their original
phosphotransfer function but during evolution have adopted
signal perception functions and may thus represent a large class of
so-far unrecognized kinase input domains.
Similar to the two identified DDR mutants, the kinase activity
of ShkA is also uncoupled from c-di-GMP when conserved
residues of REC2 are mutated (Supplementary Fig. 2e) or when
the C-terminal REC2 domain is removed from the catalytic core
(DHp, CA, and REC1 domain) (Fig. 1h). Thus, the REC2 domain
and the DDR linker motif inhibit ShkA autophosphorylation,
maintaining it in an inactive state. We propose that c-di-GMP
binding to REC1 overrides this auto-inhibition and activates the
enzyme.
C-di-GMP defines a narrow window of ShkA activity during
G1/S. The c-di-GMP-independent variants of ShkA allowed us to
more carefully investigate the role of ShkA in the temporal
control of events during G1/S. Introduction of the shkAD369N
allele into the rcdG0 strain restored SpmX protein levels, stalk
biogenesis, DivJ localization to the incipient stalked pole, and
normal cell morphology (Fig. 3a, b; Supplementary Fig. 6a). Of
note, shkAD369N failed to restore G2-specific processes in the
rcdG0 strain like motility and type IV pili assembly (Supple-
mentary Fig. 6b, c). Restoration of cell morphology and DivJ
localization was entirely dependent on SpmX (Fig. 3b), arguing
that c-di-GMP and ShkA contribute to cell cycle progression and
morphogenesis via spmX expression control. Consistent with this
notion, the shkAD369N allele rescued the synthetic-lethal pheno-
type of a strain lacking c-di-GMP and suffering from reduced
DivK levels9 in a SpmX-dependent manner (Supplementary
Fig. 6), indicating that ShkA influences the CckA kinase/phos-
phatase balance. A strain harboring the shkAD369N allele prema-
turely produced SpmX already in newborn G1 cells (Fig. 3c).
Accordingly, the shkAD369N mutant exited G1 prematurely, as
indicated by the strong reduction of G1 cells (Fig. 3d). Likewise,
cells failed to properly arrest in G1 after entry into the stationary
phase (Fig. 3d, e). Growth rate of the shkAD369N mutant was not
increased in either PYE or M2G medium compared with wild
type, suggesting that the overall length of the cell cycle (combined
G1, S, and G2 phases) is not or only marginally affected (Sup-
plementary Fig. 6). These results support a role of c-di-GMP, and
the ShkA-TacA pathway, in the timely execution of the G1/S
transition.
TacA was previously shown to be degraded by the ClpXP
protease, a process that requires the adapter proteins RcdA and
CpdR and depends on the C-terminal Ala–Gly degradation motif
of TacA16. ShkA harbors the same C-terminal degradation signal
and was also degraded upon S-phase entry about 10 min after the
removal of TacA (Fig. 3f). When the C-terminal Ala–Gly motif
was replaced by Asp residues (ShkADD), ShkA and ShkA~P were
stabilized and prevailed throughout the cell cycle (Fig. 3f).
Sequential degradation of TacA and ShkA may be explained by
their differential requirements for protease adapters. While TacA
degradation by ClpXP depends on CpdR and RcdA16, ShkA
degradation also requires PopA, the third member of the adapter
hierarchy regulating ClpXP protease activity during the C.
crescentus cell cycle (Fig. 3g, h). Because PopA needs to bind c-
di-GMP to act as a protease adapter17, the ShkA-TacA pathway is
confined to G1/S by the sequential c-di-GMP-dependent
activation and c-di-GMP-mediated degradation of the ShkA
kinase.
The ShkA-TacA pathway limits gene expression to G1/S. To
carefully assess the contribution of ShkA activation and degra-
dation for the temporal control of spmX, the spmX promoter was
fused to the fluorescent protein Dendra2. The photoconvertible
properties of Dendra218 allowed determining both “ON” and
“OFF” kinetics of spmX promoter activity during the cell cycle
(Fig. 4b; Supplementary Fig. 7a). These experiments revealed that
spmX promoter activity peaks during G1/S roughly 15–30 min
after passing through the predivisional stage (Fig. 4b). The spmX
promoter was active in cells progressing through G1/S, but not in
newborn ST progeny that reenter S-phase immediately at the end
of the asymmetric cell cycle (Fig. 4a, c; Supplementary Fig. 7a–c).
Stage-specific expression of spmX required a combination of c-di-
GMP oscillations during the cell cycle and TacA degradation:
expression of combinations of dgcZ, a gene encoding a highly
active DGC from E. coli19, and of tacADD (encoding stable
TacA16) and shkAD369N (encoding constitutive ShkA) alleles
resulted in a gradual loss of G1/S-specific spmX expression
Fig. 2 C-di-GMP binds to the REC1 pseudo-receiver domain. a ShkA domain architecture drawn to scale (top) and alignment of the REC1-REC2 linker
harboring the DDR motif (highlighted in green) of ShkA orthologs (bottom). Ccr, C. crescentus; Cse, Caulobacter segnis; Che, Caulobacter henricii; K31,
Caulobacter sp. K31; Pzu, Phenylobacterium zucineum; Abi, Asticcacaulis biprosthecium; Aex, Asticcaucaulis excentricus; Bsu, Brevundimonas subvibrioides.
Dimerization and histidine-phosphotransfer (DHp), catalytic and ATP-binding (CA) and receiver (REC1, REC2) domains are indicated. b Activity of the
spmX promoter in indicated strains harboring plasmid pAK502-spmX. shkAD369N is expressed from the native chromosomal locus. Means and standard
deviations are shown (N= 3). c Phos-tag PAGE immunoblots of indicated strains producing 3xFLAG-tagged TacA or TacADD from the native locus. d In
vitro autophosphorylation assays of ShkA and ShkAD369N. Top: autoradiograph; bottom: Coomassie stain. e β-Gal assays of ΔshkA mutant strains
harboring plasmid pAK502-spmX and expressing different shkA alleles in trans from plasmid pQF with the indicated amino acid substitutions alone (WT,
white bars) or in combination with D369N (blue bars). Shown are means and standard deviations (N= 3). f In vitro autophosphorylation assays of wild
type or mutant ShkA with (10 µM) or without c-di-GMP. Reactions were run for 5 min. Top: autoradiograph; bottom: Coomassie stain. g Autoradiographs
of purified ShkA and ShkA mutant variants (0.5 µM) UV-crosslinked with 10 µM [32P]c-di-GMP with or without addition of a 50-fold molar excess of non-
labeled c-di-GMP. Top: autoradiograph; bottom: Coomassie stain. h Quantified autoradiographs of purified ShkA and ShkAY338A (0.5 µM) UV-crosslinked
with increasing concentrations of [32 P]c-di-GMP. Shown are mean values and standard deviations (N= 2). i Autoradiographs and Coomassie stain of the
same gel of purified ShkA and the isolated REC1 domain (ShkAREC1) (0.5 µM) after UV crosslinking with 10 µM [32P]c-di-GMP (top). Quantified
autoradiographs of purified ShkA and ShkAREC1 (0.5 µM) after UV crosslinking with increasing concentrations of [32P]c-di-GMP (bottom). Means and
standard deviations are shown (N= 2). j Cartoon and surface representation of the ShkAREC1 homology model with NMR chemical shift perturbations
(CSPs) upon c-di-GMP binding indicated by a blue-to-yellow gradient. k Conservation score of ShkA orthologs (see “Methods”). Source data are provided
as a Source Data file.
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(Fig. 4c; Supplementary Fig. 7c). These experiments provided
direct evidence that the activity of the ShkA-TacA pathway is
strictly limited to G1/S and SW progeny that need to passage
through the G1 phase of the cell cycle.
To investigate the importance of limiting the ShkA-TacA
pathway to G1/S for accurate cell cycle progression, we examined
the consequences of ShkA-TacA dysregulation using stable
(TacADD, ShkADD), or constitutively active (ShkAD369N)
variants or combinations thereof. All alleles increased overall
spmX expression and showed additive effects when combined
(Supplementary Fig. 8a). Cell division and cell morphology were
normal in all strains that either retained TacA degradation or c-
di-GMP-mediated ShkA activity control. However, when muta-
tions that stabilize ShkA or TacA were combined with a
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mutation constitutively activating ShkA, strains showed strong
cell division and morphology aberrations, effects that were
strictly dependent on an intact copy of spmX (Fig. 4d;
Supplementary Fig. 8b). Thus, dysregulation of the SpmX
morphogen leads to aberrant cell morphogenesis. Together,
these experiments provide evidence that dysregulation of ShkA-
TacA activity leads to severe cell cycle and morphological defects.
The diguanylate cyclase PleD activates ShkA during G1/S. The
above data support a model in which an upshift of c-di-GMP
stimulates ShkA kinase activity thereby initiating the G1/S-spe-
cific genetic program (Fig. 5a). If so, the G1/S transition should be
kick-started by one of the C. crescentus diguanylate cyclases.
Screening a spmX-lacZ reporter strain for transposon insertions
with reduced lacZ expression identified mutations in pleD.
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Accordingly, a ΔpleD deletion strain showed strongly reduced
spmX expression (Fig. 5b). While a second diguanylate cyclase
enzyme, DgcB, had a more modest effect, spmX promoter activity
was almost completely abolished in a ΔpleD ΔdgcB double
mutant, akin to a strain lacking c-di-GMP (Fig. 5b). Thus, PleD is
the major diguanylate cyclase driving the G1/S-specific tran-
scriptional program.
PleD phosphorylation is regulated by the antagonistic ST cell-
specific kinase DivJ and the SW cell-specific phosphatase PleC
(Figs. 1a and 5a)8. However, PleC but not DivJ, was required for
spmX expression, and spmX expression was restored to normal
levels in a strain lacking both PleC and DivJ (Fig. 5b). This
indicated that neither DivJ nor PleC is responsible for the initial
activation of PleD and for ShkA stimulation, and that the role of
PleC is likely indirect. PleC phosphatase was previously shown to
reduce DivK phosphorylation leading to the activation of CtrA.
Because tacA is a direct target of CtrA, it was proposed that in a
ΔpleC mutant, spmX expression is impaired because TacA fails to
accumulate12. Expression of tacA and spmX indeed required the
PleC phosphatase (Fig. 5c, d). However, when the pleC deletion
was combined with the constitutive shkAD369N allele, SpmX
protein levels and polar localization of DivJ, but not tacA
expression, were fully restored (Fig. 5c, e; Supplementary Fig. 9),
arguing that TacA levels are not the limiting factor in cells lacking
PleC. Rather, ShkA activity and its stimulation by c-di-GMP are
switched off in the ΔpleC mutant. Indeed, a constitutively active
variant of PleD, PleD*15, restored SpmX protein levels in the
ΔpleC mutant, an effect that was entirely dependent on ShkA
(Fig. 5f). These results suggest that c-di-GMP levels are limiting in
a ΔpleC mutant. In line with this, LC-MS measurements showed
that the ΔpleC mutant has significantly reduced c-di-GMP levels
as compared with the isogenic pleC+ strain (9.5 ± 1.3 µM vs.
16.3 ± 0.5 µM; N= 3).
The finding that the ShkA-TacA pathway is OFF in the ΔpleC
mutant because c-di-GMP concentrations are limiting, together
with the observation that PleD serves as the main c-di-GMP
donor for ShkA activation, argues for the existence of an as yet
unidentified PleD kinase, the expression of which will likely
depend on the PleC-CckA-CtrA cascade. We speculate that
activation of this kinase and its downstream target PleD
represents a key event in the decision of C. crescentus to exit
G1 (Fig. 5a).
Discussion
C. crescentus SW cells are born with low levels of c-di-GMP11,20.
This is imposed by two cell type-specific regulators, the phos-
phodiesterases PdeA21 and the phosphatase PleC, which maintains
the diguanylate cyclase PleD in its inactive, unphosphorylated
form8 (Fig. 5a). During the G1/S transition, PdeA is proteolytically
removed21 and PleD is activated by phosphorylation. This results
in a gradual increase of c-di-GMP11,20, which leads to a series of
accurately timed events prompting exit from G1, cell morpho-
genesis and entry into S-phase. First, ShkA is allosterically acti-
vated resulting in TacA phosphorylation and the expression of a
large group of G1/S-specific genes that orchestrate the morpho-
logical restructuring of the motile SW cells into sessile ST cells13,14.
At this stage, c-di-GMP levels are high enough to activate ShkA-
TacA but have not reached the peak levels needed to trigger the
CckA cell cycle switch and S-phase entry8,9. This leads to the
execution of the morphogenetic program before cells commit to
chromosome replication and division. The next step is then cata-
lyzed by the expression of one of the G1/S-specific proteins, the
morphogen SpmX, which is responsible for the polar sequestration
and activation of DivJ12. This, in turn, leads to the production of
more c-di-GMP via reinforced activation of PleD and, together
with DivJ-mediated phosphorylation of DivK, switches CckA into
a phosphatase and ultimately licenses replication initiation7–9
(Fig. 5a). ShkA binds c-di-GMP with five- to tenfold higher
affinity than CckA9,17 explaining how the ShkA-TacA pathway
and the CckA switch can be sequentially activated. Thus, at
least four kinases form a hierarchical cascade (HK→ShkA→
DivJ→CckA) that is responsible for the accurate temporal control
of events during G1/S. The activity and timing of this cascade is
coordinated by the second messenger c-di-GMP, a stepwise
increase of which enforces consecutive cell cycle steps by mod-
ulating the activity of ShkA and CckA, respectively (Fig. 5a).
By contributing to the CckA phosphatase switch via SpmX
and DivJ, the ShkA-TacA pathway initiates its own termina-
tion. The CckA phosphatase activates a protease adapter cas-
cade that includes CpdR and PopA16 and that leads to the
consecutive degradation of TacA and ShkA by the ClpXP
protease (Fig. 5a). This negative feedback constitutes an
intrinsic, self-sustained timer that shuts down ShkA-TacA
activity as soon as c-di-GMP has reached peak levels required
to activate the CckA phosphatase and the PopA protease
adapter, thereby irreversibly committing cells to S-phase.
Because TacA not only controls genes involved in cell cycle
progression but also regulates morphological restructuring of
the motile SW cells into sessile ST cells13,14, accurate temporal
control of this pathway secures the tight coordination between
replicative and behavioral processes.
Our results show that the diguanylate cyclase PleD is largely
responsible for the c-di-GMP upshift during G1-S transition. We
postulate that the initial event leading to PleD activation during
G1/S must be executed by a kinase other than DivJ or PleC, and
that DivJ is part of a positive feedback loop that reinforces PleD
Fig. 4 Oscillation of c-di-GMP and protein degradation limit TacA activity to G1/S. a Time-lapse fluorescence microscopy of C. crescentus wild-type cells
expressing dendra2 from the spmX promoter. The time of photoconversion of Dendra2 (green to red) in the predivisional cell (PD) is indicated in the
schematic of the C. crescentus cell cycle. A representative example of a dividing cell is shown below with separate green and red channels and with the ST
cell pole of the PD cell marked (orange arrow). spmX expression (green) is restricted to the SW cell during G1/S transition (white arrows). The bar is 1 μm.
b ON and OFF kinetics of spmX promoter activity during G1/S in wild-type cells harboring the spmX-dendra2 reporter plasmid. ON kinetics were determined
as outlined in a with cells being photoconverted before division (0min) and the fraction of ST (gray circles) and SW cells (green circles) with induced
green fluorescence plotted over time. OFF kinetics were determined by the fraction of SW cells with induced green fluorescence after photoconversion at
the indicated time points during the cell cycle (blue boxes). The overlap of the two curves (green area) defines the window of spmX promoter activity
during the cell cycle. c Activity of spmX promoter in lineages of individual C. crescentus cells of different strains through three consecutive generations as
indicated by the schematic on the left. The projected G1/S-specific expression of spmX is indicated in green. For each strain 10–16 late PD harboring the
spmX-dendra2 reporter were photoconverted roughly 15 min before cell division and followed by time-lapse microscopy through three cell division events.
Right: The fraction of SW and ST offspring (% of total cells analyzed) with active spmX promoter (green) was plotted over three generations with the x-axis
representing generations 1–3. For experimental details and data analysis see “Methods”. C-di-GMP levels were manipulated by Plac-driven dgcZ with 0.1
mM IPTG. EV, empty vector control. d Representative phase-contrast micrographs of strains carrying different shkA and tacA alleles encoding stabilized
(shkADD and tacADD) or c-di-GMP-independent (shkAD369N) versions of the respective proteins. The scale bar represents 4 µm.
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activity upon S-phase entry (Fig. 5a). Although the nature of this
kinase is currently unknown, we speculate that its expression or
activity is CtrA-dependent and that it plays a key role in
orchestrating exit from G1 as it may not only serve to activate
PleD and provide the initial boost of c-di-GMP but may also
contribute to the activation of DivK, a factor required for the
CckA kinase/phosphatase switch. The essential nature of DivK
but not of DivJ, its only known activating kinase, argues for
regulatory redundancy in the upstream components required to
boost DivK phosphorylation during G1/S (Fig. 5a).
We postulate that in its default state, the ShkA kinase is
inhibited by the C-terminal REC2 domain and that c-di-GMP
binding liberates the kinase by interfering with this off-state
conformation. A ShkA variant lacking the REC2 domain is active
without c-di-GMP13. Similarly, mutations of residues important
for REC2 function lead to constitutive, c-di-GMP-independent
autokinase activity. Thus, the conserved DDR motif in the REC1-
REC2 linker likely serves to lock ShkA in the inactive state when
no c-di-GMP is present. REC2 may be closely tethered to REC1 in
the inactive state through an interaction of the DDR linker motif
with REC1, a conformation that may prevent the productive
interaction of the catalytic CA with the DHp domain. We
hypothesize that binding of c-di-GMP to REC1 interferes with
this tethering, thereby liberating REC2 and facilitating the pro-
ductive interaction between CA and DHp for autopho-
sphorylation and eventually for phosphotransfer between DHp
and REC2. This model is strongly supported by an accompanying
structural analysis of ShkA22.
These findings demonstrate that degenerate REC domains, also
called pseudo-receiver domains, can function as docking sites for
small regulatory molecules. Hybrid histidine kinases with pseudo-
receiver domains located between the CA and the phosphorylated
receiver domain are widespread in bacteria and include the well-
studied virulence factors of the GacS/BarA family23,24 or the
global stress regulator RcsC25,26 (Supplementary Fig. 5). For
instance, the pseudo-receiver of RcsC can only be recognized by
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to G1/S transition. HK indicates a hypothetical histidine kinase that controls the activity of PleD and possibly DivK (stippled lines) and by that acts as kick-
starter for G1 exit. HK expression is postulated to be CtrA-mediated (stippled line). The initial, HK-PleD-mediated increase of c-di-GMP activates the ShkA-
TacA pathway, resulting in a SpmX-DivJ-PleD-mediated further boost of c-di-GMP concentration, which activates the CckA phosphatase and PopA. Note
that ShkA has a five- to tenfold higher affinity for c-di-GMP compared with CckA and PopA. The block of replication initiation by binding of activated CtrA
to the chromosomal origin of replication (Cori) is indicated. The lower part of the graph indicates time windows of CckA kinase and phosphatase as well as
TacA kinase activity. The gradual increase of c-di-GMP during G1/S is indicated. b Activity of the spmX promoter in strains harboring a spmX’-‘lacZ reporter
fusion (pAK502-spmX). Shown are mean values and standard deviations (N= 3). c Activity of the tacA promoter in strains harboring a tacA’-‘lacZ fusion
(pAK502-tacA). Strains with a chromosomal pleC deletion express wild type and mutant pleC alleles from plasmid pQF under control of their native
promoter. PleC(F778L): Kinase−/phosphatase+ (K−P+); PleC(T614R) kinase−/phosphatase− (K−P−); - indicates the empty vector control (plasmid
pQF). Shown are mean values and standard deviations (N= 3). d Immunoblots of selected strains shown in c probed with anti-SpmX and anti-MreB
antibodies (top) or anti-PleC antibodies (bottom). e Immunoblots of selected strains shown in c probed with anti-SpmX and anti-MreB antibodies.
f Immunoblots of indicated strains probed with anti-SpmX and anti-MreB antibodies. pPleD* indicates a pMR20-based plasmid (pPA114-47) expressing the
constitutively active, phosphorylation-independent PleD* allele. EV denotes the empty plasmid control (pMR20). Source data are provided as a Source
Data file.
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structural comparison25, arguing that primary structure-based
searches largely underestimate the actual number of these mod-
ules. It is possible that pseudo-receiver domains generally serve as
binding sites for metabolites or small signaling molecule thereby
modulating kinase or phosphatase activity of such key bacterial
regulators. In line with this, prominent examples of kinases
harboring pseudo-receiver domains like GacS in P. aeruginosa or
BarA and RcsC in E. coli are part of complex signaling cascades
that globally regulate bacterial physiology and behavior. Careful
scrutiny of the exact function of these domains will be essential to
improve our understanding of such important regulatory nodes
in bacteria.
Methods
Growth conditions. Caulobacter crescentus was grown in PYE (0.2% [w/v] bacto
peptone, 0.1% [w/v] yeast extract, 0.8 mM MgSO4, 0.5 mM CaCl2) or defined M2G
(12.2 mM Na2HPO4, 7.8 mM KH2PO4, 9.3 mM NH4Cl, 0.5 mM MgSO4, 0.5 mM
CaCl2, 20 µM FeSO4, 0.2% [w/v] D-glucose) medium at 30 °C. Growth in low-
phosphate medium (PYETris) was performed by replacing the phosphate buffer
components in M2G with 20 mM Tris-HCl (pH 7.0)12,29. Standard plates con-
tained 1.5% [w/v] agar. Motility was assayed on PYE plates containing 0.3% agar.
Escherichia coli DH5α, DH10B, or TOP10 were used for cloning and were routinely
cultivated in LB-Miller at 37 °C. When appropriate, media were supplemented with
antibiotics at the following concentrations unless stated otherwise (liquid/solid
media for C. crescentus; liquid/solid media for E. coli; in μg ml−1): kanamycin (5/
20; 30/50), oxytetracycline (2.5/5; 12.5/12.5), chloramphenicol (1/2; 20/30), gen-
tamycin (1/5; 20/20), spectinomycin (25/50; −/−), streptomycin (5/5; −/−),
ampicillin (−/−; 100/100), nalidixic acid (15/20; −/−). Isopropy-β-D-
thiogalactopyranoside (IPTG), 4-hydroxy-3-methoxybenzoic acid (vanillate), and
xylose stocks were prepared in ddH2O at concentrations of 1M, 200 mM, and 20%
[w/v], respectively, and used at final concentrations of 300 µM, 250 µM, and 0.2%
in C. crescentus, if not otherwise stated. 4-isopropylbenzoic acid (cumate) stocks
(100 mM) were prepared in 100% ethanol and used at a final concentration of
100 µM. Note that for experiments in which shkA alleles were provided on plasmid
pQF in trans no cumate was present since already leaky expression of the wild-type
allele could complement the ΔshkA null mutant phenotype.
Strains and plasmids. Plasmids are listed in Supplementary Data 2. Oligonu-
cleotides used for plasmid construction were purchased from Sigma and are listed
in Supplementary Data 3. Plasmids were constructed as follows:
pAK503: nptII without RBS and start codon was PCR-amplified from pAK405
using primers 8959/9495, the product was digested with BsrGI/XbaI and cloned
into pAK501 cut with Acc65I/XbaI.
pAK502-tacA: the spmX promoter and part of the codon sequence were PCR-
amplified from C. crescentus gDNA using primers 10015/10016, the product was
digested with XbaI/KpnI and cloned into pAK502 digested with the same enzymes.
pAK502-spmX: the spmX promoter and part of the codon sequence were PCR-
amplified from C. crescentus gDNA using primers 8966/9064, the product was
digested with XbaI/KpnI and cloned into pAK502 digested with the same enzymes.
pAK503-spmX: the spmX promoter and part of the codon sequence were PCR-
amplified from C. crescentus gDNA using primers 8966/9064, the product was
digested with XbaI/KpnI and cloned into pAK503 digested with the same enzymes.
pNPTStet: tetA and tetR were PCR-amplified from pQF using primers 9552/
9553, the product was digested with SpeI/NdeI and cloned into pNPTS138 digested
with AseI/XbaI.
pNPTStet-ampG: part of ampG located downstream of shkA was PCR-amplified
from C. crescentus gDNA with primers 9554/9555, the product was digested with
SpeI/KpnI and cloned into pNPTStet digested with the same enzymes.
pET28a-shkA: shkA was PCR-amplified from C. crescentus gDNA with primers
9745/9746, the product was digested with NdeI/EcoRI and cloned into pET28a
digested with the same enzymes.
pET28a-shkA(D369N): shkA(D369N) was amplified from C. crescentus strain
UJ9618 by colony-PCR using primers 9745/9746, the product was digested with
NdeI/EcoRI and cloned into pET28a digested with the same enzymes.
pQF-shkA: shkA was PCR-amplified from C. crescentus gDNA with primers
9745/9746, the product was digested with NdeI/EcoRI and cloned into pQF
digested with AseI/EcoRI.
pQF-shkA(D369N): shkA(D369N) was amplified from C. crescentus strain
UJ9618 by colony-PCR using primers 9745/9746, the product was digested with
NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI.
pQF-shkA(R26A): the mutant allele was generated by SOE-PCR using pET28a-
shkA as template and flanking primers 669/670 and mutagenic primers 9904/9905.
The product was digested with NdeI/EcoRI and cloned into pQF digested with
AseI/EcoRI.
pQF-shkA(H61A): the mutant allele was generated by SOE-PCR using pET28a-
shkA as template and flanking primers 669/670 and mutagenic primers 9968/9969.
The product was digested with NdeI/EcoRI and cloned into pQF digested with
AseI/EcoRI.
pQF-shkA(R74A): the mutant allele was generated by SOE-PCR using pET28a-
shkA as template and flanking primers 669/670 and mutagenic primers 9970/9971.
The product was digested with NdeI/EcoRI and cloned into pQF digested with
AseI/EcoRI. This shkA allele contains a second mutation, A451V.
pQF-shkA(W113A): the mutant allele was generated by SOE-PCR using
pET28a-shkA as template and flanking primers 669/670 and mutagenic primers
9906/9907. The product was digested with NdeI/EcoRI and cloned into pQF
digested with AseI/EcoRI. This shkA allele contains a second mutation, A451V.
pQF-shkA(D125N): the mutant allele was generated by SOE-PCR using
pET28a-shkA as template and flanking primers 669/670 and mutagenic primers
10009/10010. The product was digested with NdeI/EcoRI and cloned into pQF
digested with AseI/EcoRI.
pQF-shkA(R128A): the mutant allele was generated by SOE-PCR using pET28a-
shkA as template and flanking primers 669/670 and mutagenic primers 10005/
10006. The product was digested with NdeI/EcoRI and cloned into pQF digested
with AseI/EcoRI.
pQF-shkA(R130A): the mutant allele was generated by SOE-PCR using pET28a-
shkA as template and flanking primers 669/670 and mutagenic primers 10007/
10008. The product was digested with NdeI/EcoRI and cloned into pQF digested
with AseI/EcoRI.
pQF-shkA(R128A, R130A): the mutant allele was generated by SOE-PCR using
pET28a-shkA as template and flanking primers 669/670 and mutagenic primers
9908/9909. The product was digested with NdeI/EcoRI and cloned into pQF
digested with AseI/EcoRI.
pQF-shkA(R177A): the mutant allele was generated by SOE-PCR using pET28a-
shkA as template and flanking primers 669/670 and mutagenic primers 9910/9911.
The product was digested with NdeI/EcoRI and cloned into pQF digested with
AseI/EcoRI. This shkA allele contains a second mutation, P233L.
pQF-shkA(F230A, F234A): the mutant allele was generated by SOE-PCR using
pET28a-shkA as template and flanking primers 669/670 and mutagenic primers
9972/9973. The product was digested with NdeI/EcoRI and cloned into pQF
digested with AseI/EcoRI.
pQF-shkA(D297N): the mutant allele was generated by SOE-PCR using
pET28a-shkA as template and flanking primers 669/670 and mutagenic primers
9974/9975. The product was digested with NdeI/EcoRI and cloned into pQF
digested with AseI/EcoRI.
pQF-shkA(P321A): the mutant allele was generated by SOE-PCR using pET28a-
shkA as template and flanking primers 669/670 and mutagenic primers 10013/
10014. The product was digested with NdeI/EcoRI and cloned into pQF digested
with AseI/EcoRI.
pQF-shkA(R324A): the mutant allele was generated by SOE-PCR using pET28a-
shkA as template and flanking primers 669/670 and mutagenic primers 9912/9913.
The product was digested with NdeI/EcoRI and cloned into pQF digested with
AseI/EcoRI.
pQF-shkA(D325N): the mutant allele was generated by SOE-PCR using
pET28a-shkA as template and flanking primers 669/670 and mutagenic primers
10011/10012. The product was digested with NdeI/EcoRI and cloned into pQF
digested with AseI/EcoRI.
pQF-shkA(I327A): the mutant allele was generated by SOE-PCR using pET28a-
shkA as template and flanking primers 669/670 and mutagenic primers 9976/9977.
The product was digested with NdeI/EcoRI and cloned into pQF digested with
AseI/EcoRI. This shkA allele contains a second mutation, A451V.
pQF-shkA(Y338A): the mutant allele was generated by SOE-PCR using pET28a-
shkA as template and flanking primers 669/670 and mutagenic primers 9978/9979.
The product was digested with NdeI/EcoRI and cloned into pQF digested with
AseI/EcoRI.
pQF-shkA(R344A): the mutant allele was generated by SOE-PCR using pET28a-
shkA as template and flanking primers 669/670 and mutagenic primers 9914/9915.
The product was digested with NdeI/EcoRI and cloned into pQF digested with
AseI/EcoRI. This shkA allele contains a second mutation, A451V.
pQF-shkA(E402A, G403A): the mutant allele was generated by SOE-PCR using
pET28a-shkA as template and flanking primers 669/670 and mutagenic primers
9980/9981. The product was digested with NdeI/EcoRI and cloned into pQF
digested with AseI/EcoRI.
pQF-shkA(C404A): the mutant allele was generated by SOE-PCR using pET28a-
shkA as template and flanking primers 669/670 and mutagenic primers 9986/9987.
The product was digested with NdeI/EcoRI and cloned into pQF digested with
AseI/EcoRI.
pQF-shkA(D430N): the mutant allele was generated by SOE-PCR using
pET28a-shkA as template and flanking primers 669/670 and mutagenic primers
10028/10029. The product was digested with NdeI/EcoRI and cloned into pQF
digested with AseI/EcoRI.
pQF-shkA(D465A): the mutant allele was generated by SOE-PCR using
pET28a-shkA as template and flanking primers 669/670 and mutagenic
primers 9982/9983. The product was digested with NdeI/EcoRI and cloned into
pQF digested with AseI/EcoRI. This shkA allele contains a second mutation,
A451V.
pQF-shkA(C469A): the mutant allele was generated by SOE-PCR using pET28a-
shkA as template and flanking primers 669/670 and mutagenic primers 9984/9985.
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The product was digested with NdeI/EcoRI and cloned into pQF digested with
AseI/EcoRI. This shkA allele contains a second mutation, A451V.
pQF-shkA(K341): the mutant allele was generated by SOE-PCR using pET28a-
shkA as template and flanking primers 669/670 and mutagenic primers 11171/
11172. The product was digested with NdeI/EcoRI and cloned into pQF digested
with AseI/EcoRI.
pQF-shkA(P342A): the mutant allele was generated by SOE-PCR using pET28a-
shkA as template and flanking primers 669/670 and mutagenic primers 11173/
11174. The product was digested with NdeI/EcoRI and cloned into pQF digested
with AseI/EcoRI.
pQF-shkA(L343A): the mutant allele was generated by SOE-PCR using pET28a-
shkA as template and flanking primers 669/670 and mutagenic primers 11175/
11176. The product was digested with NdeI/EcoRI and cloned into pQF digested
with AseI/EcoRI.
pQF-shkA(I340A): the mutant allele was generated by SOE-PCR using pET28a-
shkA as template and flanking primers 669/670 and mutagenic primers 11177/
11178. The product was digested with NdeI/EcoRI and cloned into pQF digested
with AseI/EcoRI.
pQF-shkA(L338A): the mutant allele was generated by SOE-PCR using pET28a-
shkA as template and flanking primers 669/670 and mutagenic primers 11179/
11180. The product was digested with NdeI/EcoRI and cloned into pQF digested
with AseI/EcoRI.
pQF-shkA(G337A): the mutant allele was generated by SOE-PCR using
pET28a-shkA as template and flanking primers 669/670 and mutagenic primers
11181/11182. The product was digested with NdeI/EcoRI and cloned into pQF
digested with AseI/EcoRI.
pQF-shkA(K331A): the mutant allele was generated by SOE-PCR using
pET28a-shkA as template and flanking primers 669/670 and mutagenic primers
11183/11184. The product was digested with NdeI/EcoRI and cloned into pQF
digested with AseI/EcoRI.
pQF-shkA(S347A): the mutant allele was generated by SOE-PCR using pET28a-
shkA as template and flanking primers 669/670 and mutagenic primers 11185/
11186. The product was digested with NdeI/EcoRI and cloned into pQF digested
with AseI/EcoRI.
pQF-shkA(Q351A): the mutant allele was generated by SOE-PCR using
pET28a-shkA as template and flanking primers 669/670 and mutagenic primers
11187/11188. The product was digested with NdeI/EcoRI and cloned into pQF
digested with AseI/EcoRI.
pQF-shkA(D369N, H61A): a fragment harboring part of shkA was released from
pQF-shkA(H61A) by digestion with SpeI/PstI and cloned into pQF-shkA(D369N)
digested with the same enzymes.
pQF-shkA(D369N, R128A): a fragment harboring part of shkA was released
from pQF-shkA(R128A) by digestion with SpeI/PstI and cloned into pQF-shkA
(D369N) digested with the same enzymes.
pQF-shkA(D369N, R130): a fragment harboring part of shkA was released from
pQF-shkA(R130A) by digestion with SpeI/PstI and cloned into pQF-shkA(D369N)
digested with the same enzymes.
pQF-shkA(D369N, R128A, R130A): a fragment harboring part of shkA was
released from pQF-shkA(R128A, R130A) by digestion with SpeI/PstI and cloned
into pQF-shkA(D369N) digested with the same enzymes.
pQF-shkA(D369N, F230A, F234A): a fragment harboring part of shkA was
released from pQF-shkA(F230A, F234A) by digestion with SpeI/PstI and cloned
into pQF-shkA(D369N) digested with the same enzymes.
pQF-shkA(D369N, R128A): a fragment harboring part of shkA was released
from pQF-shkA(R128A) by digestion with SpeI/PstI and cloned into pQF-shkA
(D369N) digested with the same enzymes.
pQF-shkA(D369N, R324A): a fragment harboring part of shkA was released
from pQF-shkA(R324A) by digestion with SpeI/PstI and cloned into pQF-shkA
(D369N) digested with the same enzymes.
pQF-shkA(D369N, Y338A): a fragment harboring part of shkA was released
from pQF-shkA(Y338A) by digestion with SpeI/PstI and cloned into pQF-shkA
(D369N) digested with the same enzymes.
pET28a-shkA(D430N): the mutant allele was generated by SOE-PCR using
pET28a-shkA as template and flanking primers 669/670 and mutagenic primers
10028/10029. The product was digested with NdeI/EcoRI and cloned into pET28a
digested with NdeI/EcoRI.
pET28a-shkA(E386Q, D387N): the mutant allele was generated by SOE-PCR
using pET28a-shkA as template and flanking primers 669/670 and mutagenic
primers 10026/10027. The product was digested with NdeI/EcoRI and cloned into
pET28a digested with NdeI/EcoRI.
pET28a-shkA(K480R): the mutant allele was generated by SOE-PCR using
pET28a-shkA as template and flanking primers 669/670 and mutagenic primers
10024/10025. The product was digested with NdeI/EcoRI and cloned into pET28a
digested with NdeI/EcoRI.
pET28a-shkA(R324A): a fragment harboring part of shkA was released from
pQF-shkA(R324A) by digestion with AscI/PstI and cloned into pET28a-shkA
digested with the same enzymes.
pET28a-shkA(D369N, R324A): a fragment harboring part of shkA was released
from pQF-shkA(R324A) by digestion with AscI/PstI and cloned into pET28a-shkA
(D369N) digested with the same enzymes.
pET28a-shkA(Y338A): a fragment harboring part of shkA was released from
pQF-shkA(Y338A) by digestion with AscI/PstI and cloned into pET28a-shkA
digested with the same enzymes.
pET28a-shkA(D369N, Y338A): a fragment harboring part of shkA was released
from pQF-shkA(Y338A) by digestion with AscI/PstI and cloned into pET28a-shkA
(D369N) digested with the same enzymes.
pET28a-shkA(R128A, R130A): the mutant allele was generated by SOE-PCR
using pET28a-shkA as template and flanking primers 669/670 and mutagenic
primers 9908/9909. The product was digested with NdeI/EcoRI and cloned into
pET28a digested with the same enzymes.
pET28a-shkA-REC1: a fragment of shkA encoding REC1 was PCR-amplified
from C. crescentus gDNA with primers 10862/10866, the product was digested with
NdeI/KpnI and cloned into pUC18 digested with the same enzymes. A NdeI/EcoRI
from the resulting plasmid was subcloned into pET28a digested with the same
enzymes.
pQF-pleC: a DNA fragment including pleC ORF and the mapped pleC promoter
as PCR-amplified from plasmid pJS14-pleC with primers 10781/10783, the product
was digested with SpeI/KpnI and cloned into pQF digested with the same enzymes.
pQF-pleC(K−P−): a DNA fragment including pleC(T614R) ORF and the
mapped pleC promoter as PCR-amplified from plasmid pJS14-pleC(T615R) with
primers 10781/10783, the product was digested with SpeI/KpnI and cloned into
pQF digested with the same enzymes.
pQF-pleC(K−P+): a DNA fragment including pleC(F778L) ORF and the
mapped pleC promoter as PCR-amplified from plasmid pJS14-pleC(F778L) with
primers 10781/10783, the product was digested with SpeI/KpnI and cloned into
pQF digested with the same enzymes.
pdivJ-mCherry: the 3′ part of divJ was PCR-amplified from C. crescentus gDNA
with primers 10205/10206, the product was digested with KpnI/AgeI and cloned
into pCHYC-4 digested with the same enzymes.
pNPTS138-ΔtacA: two DNA fragments flanking the tacA ORF were PCR-
amplified from C. crescentus gDNA. Fragment 1 was amplified with primers 6535/
6098, then digested with PstI/KpnI. Fragment 2 was amplified with primers 6099/
6536, then digested with KpnI/EcoRI. The two fragments were ligated to pNPTS138
digested with PstI/EcoRI.
pNPTS138-ΔshkA: two DNA fragments flanking the shkA ORF were PCR-
amplified from C. crescentus gDNA. Fragment 1 was amplified with primers 6085/
6086, then digested with PstI/KpnI. Fragment 2 was amplified with primers 6087/
6088, then digested with KpnI/EcoRI. The two fragments were ligated to pNPTS138
digested with PstI/EcoRI.
pNPTS138-3xFLAG-tacA: the upstream region of the tacA ORF was PCR-
amplified from C. crescentus gDNA with primers 6438/6439 (fragment 1). A 5′ part
of tacA was PCR-amplified from C. crescentus gDNA with primers 6440/7604
(fragment 2), and then used as a template with primers 6441/7604 to insert the
coding sequence of the 3xFlag-Tag (fragment 3). SOE-PCR was performed with
fragment 1 and 3 as template and primers 6438/7604. The resulting product was
then digested with PstI/EcoRI and ligated into pNPTS138 digested with the same
enzymes.
pNPTS138-3xFLAG-shkA: the upstream region of the shkA ORF was PCR-
amplified from C. crescentus gDNA with primers 6442/6443 (fragment 1). A 5′ part
of shkA was PCR-amplified from C. crescentus gDNA with primers 6444/7605
(fragment 2), and then used as a template with primers 6445/7605 to insert the
coding sequence of the 3xFlag-Tag (fragment 3). SOE-PCR was performed with
fragment 1 and 3 as template and primers 6442/7605. The resulting product was
then digested with PstI/EcoRI and ligated into pNPTS138 digested with the same
enzymes.
pNPTS138-shkA(DD): the 5′ region of shkA was PCR-amplified from C.
crescentus gDNA with primers 8169/8170 (fragment 1). The downstream region of
the shkA ORF was PCR-amplified from C. crescentus gDNA with primers 8171/
8172 (fragment 2). SOE-PCR was performed with the two fragments as template
and primers 8169/8172. The resulting product was then digested with BamHI/
EcoRI and ligated into pNPTS138 digested with the same enzymes.
pNPTS138-tacA(DD): the 5′ region of tacA was PCR-amplified from C.
crescentus gDNA with primers 7925/7716 (fragment 1). The downstream region of
the tacA ORF was PCR-amplified from C. crescentus gDNA with primers 7717/
7718 (fragment 2). SOE-PCR was performed with the two fragments as template
and primers 7925/7718. The resulting product was then digested with HindIII/
EcoRI and ligated into pNPTS138 digested with the same enzymes.
pNPTS138-tacA(D54E): the mutant allele was generated by SOE-PCR using C.
crescentus gDNA as template and flanking primers 7958/7961 and mutagenic
primers 7959/7960. The product was digested with PstI/EcoRI and cloned into
pNPTS138 digested with the same enzymes.
pNPTS138-ΔspmX: two DNA fragments flanking the spmX ORF were PCR-
amplified from C. crescentus gDNA. Fragment 1 was amplified with primers 7268/
7269, fragment 2 was amplified with primers 7270/7271. The two fragments were
joined by SOE-PCR using primers 7268/7271, digested with PstI/EcoRI, and ligated
into pNPTS138 digested with the same enzymes.
pNPTS138-ΔCC0168: the region upstream of CC0168 was amplified from C.
crescentus NA1000 gDNA with primer pairs 3490 and 3491. The PCR product was
cloned into pGEM-T Easy, sequenced, and cut out with HindIII and KpnI. The
region downstream of CC0168 was amplified from C. crescentus NA1000 gDNA
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-14585-6 ARTICLE
NATURE COMMUNICATIONS |          (2020) 11:816 | https://doi.org/10.1038/s41467-020-14585-6 |www.nature.com/naturecommunications 11
with primer pairs 3492 and 3493. The PCR product was cloned into pGEM-T Easy,
sequenced and cut out with BamHI and KpnI. Both cut PCR products were ligated
in a triple ligation with pNPTS138 digested with HindIII and BamHI.
pET28a-His-shkA: shkA was PCR-amplified from C. crescentus gDNA with
primers 5988/5486, the product was digested with NdeI/HindIII and cloned into
pET28a digested with the same enzymes.
pET28a-His-shpA: shpA was PCR-amplified from C. crescentus gDNA with
primers 6015/6016, the product was digested with HindIII/EcoRI and cloned into
pET28a digested with the same enzymes.
pET28a-His-tacA-RD: the sequence of tacA encoding the receiver domain was
PCR-amplified from C. crescentus gDNA with primers 7925/6013, the product was
digested withHindIII/EcoRI and cloned into pET28a digested with the same enzymes.
pET32b-Trx-His-shkA-HK: the sequence of shkA encoding the kinase catalytic
core including the REC1 domain was PCR-amplified from C. crescentus gDNA
with primers 6110/6011, the product was digested with HindIII/EcoRI and cloned
into pET32b digested with the same enzymes.
pET32b-Trx-His-shkA-RD2: the sequence of shkA encoding the REC2 domain
was PCR-amplified from C. crescentus gDNA with primers 6109/6009, the product
was digested with HindIII/EcoRI and cloned into pET32b digested with the same
enzymes.
pMT687-tacA: tacA was PCR-amplified from C. crescentus gDNA with primers
5487/5490, the product was digested with NdeI/KpnI and cloned into pMT687
digested with the same enzymes.
pMT687-tacA(D54E): the mutant allele was generated by SOE-PCR using C.
crescentus gDNA as template and flanking primers 5487/5490 and mutagenic
primers 5488/5489. The product was digested with NdeI/KpnI and cloned into
pNPTS138 digested with the same enzymes.
pQF-PA5295: PA5295 was PCR-amplified from pRV-PA5295 with primers
8974/8975, the product was digested with HindIII/KpnI and cloned into pMT687
digested with the same enzymes.
pQF-PA5295(AAL): PA5295(AAL) was PCR-amplified from pRV-PA5295
(AAL) with primers 8974/8975, the product was digested with HindIII/KpnI and
cloned into pMT687 digested with the same enzymes.
pRKlac290-spmX: the promoter region of spmX was PCR-amplified from C.
crescentus gDNA with primers 6864/6865. The resulting product was digested with
EcoRI/PstI and ligated into pRKlac290 digested with the same enzymes.
pRKlac290-staR: the promoter region of staR was PCR-amplified from C.
crescentus gDNA with primers 6621/6622. The resulting product was digested with
EcoRI/PstI and ligated into pRKlac290 digested with the same enzymes.
pAH10: pUC19 was digested with HindIII and PciI to integrate the following
annealed oligos 5786/5903/5904/5905 downstream of the MCS.
pAH87: pMT375 was digested with XbaI and its insert was replaced with the
NsiI-PacI cassette of pAH10 amplified with 7284 and 7287 digested with NheI/SpeI.
pAH99: dendra2 was PCR-amplified from pDHL851 using primers 7503 and
7507, which also introduced a stop codon and the RBS of pQE70 upstream of
dendra2. The product was digested with HindIII and PacI and ligated into pAH87
digested with the same restriction enzymes.
pAH111: the promoter region of spmX was PCR-amplified from C. crescentus
gDNA with primers 6864 and 7512, digested with EcoRI/HindIII and ligated into
pAH99 digested with the same enzymes.
pAH139: dendra2-ssrA was generated by PCR from pDHL851 with primers
7503 and 6478. The resulting product was digested with HindIII/XhoI and ligated
into pAH111 digested with the same enzymes.
Plasmid was delivered into C. crescentus by electroporation or triparental
mating using LS980 as helper strain. φCR30 was used for generalized
transduction27. Strains are listed in Supplementary Data 4. In general, C. crescentus
mutant strains were constructed by a two-step homologous recombination
selection/counterselection procedure using pNPTS138. Alternatively, pNPTS138-
based plasmids used for construction of a specific mutant strain were first
integrated in this strain and then the mutation was moved into a clean background
using φCR30-mediated generalized transduction, followed by resolution of the
merodiploid by counterselection on PYE plates containing 0.3% [w/v] sucrose.
Synchronization. Strains were grown overnight in 5 ml PYE supplemented with
appropriate antibiotics and inducers in a roller drum at 30 °C. The next day,
cultures were diluted 20-fold in 25 ml M2G and allowed to grow on a rocking
shaker at 30 °C until they reached an OD660 of 0.4–0.6. These cultures were then
subcultured in 300 ml M2G such that the cultures reached an OD660 of 0.6 after
overnight incubation on a rocking shaker (160 rpm) at 30 °C. Cells were harvested
(5000 × g, 10 min, 4 °C), the supernatant was aspirated, cells were resuspended in
40 ml cold phosphate buffer (12.3 mM Na2HPO4, 7.8 mM KH2PO4) or in cold
M2G for experiments shown in Fig. 3c and kept at 4 °C for the rest of the pro-
cedure. 20 ml cold Ludox were added and the suspension mixed thoroughly before
being transferred to precooled glass Corex tubes and spun to separate the swarmer
from the stalked cells (9780 × g, 35 min, 4 °C). The top layer of cells was aspirated,
the swarmer band moved to a clean precooled Corex tube and washed twice with
30 ml of either cold phosphate buffer or M2G (see above) by centrifugation
(8000 × g, 10 min, 4 °C). Cells were released to a flask with pre-warmed M2G at an
OD660 of ~0.3 and incubated in a water bath (30 °C, 150 rpm). Samples were taken
at indicated time points in precooled tubes and harvested at max. speed using a
cooled table-top centrifuge. The pellets were immediately snap-frozen in liquid
nitrogen and stored at −20 °C until further processing.
Phos-tag PAGE. Samples from mixed cultures grown in PYE were taken in
exponential phase, and sampling of synchronized cultures is described above. An
equivalent of 0.5 ml cell culture at an OD660 of 0.5 was harvested by centrifugation
in a table-top centrifuge at max speed and the pellets were snap-frozen in liquid
nitrogen and stored at −20 °C. Cells were lysed in 100 µl lysis buffer (5 ml contain:
10 mM Tris-HCl pH 7.5, 4% SDS, 1 PhosSTOP tablet [Roche], a scoop of DNase I
[NEB]) for 5 min at room temperature. After spinning the samples for 5 min at
max speed at room temperature in a table-top centrifuge, 80 µl of the cell lysate was
taken up in 120 µl 1.6X SDS sample buffer (0.1 M Tris pH 6.8, 5% [v/v] glycerol,
0.2% [w/v] SDS, 1% [v/v] β-mercaptoethanol, 0.025% [w/v] bromophenol blue)
and kept on ice. Subsequently, 20 µl of sample were run on 12% SDS-PAGE gels
supplemented with 100 µM MnCl2 and 50 µM Phos-tag acrylamide compound
(Wako) for 4–5 h at 100 V at 4 °C. Subsequent immunoblotting was performed as
described below.
Immunoblotting. Samples from mixed cultures grown in PYE were taken in
exponential phase (OD660 of 0.3–0.4) and cells were harvested by centrifugation
(max speed, 1 min, room temperature) in a table-top centrifuge. Sampling of
synchronized cultures is described above. Pellets were resuspended in 1X SDS
sample buffer (62.5 mM Tri-HCl pH 6.8, 10% [v/v] glycerol, 2% [w/v] SDS, 5%
[v/v] β-mercaptoethanol, 0.001% [w/v] bromophenol blue) and boiled for
5–10 min before being run on 10–12.5% SDS-PAGE or precast Mini-Protean TGX
(Biorad) gels. Proteins were transferred from SDS-PAGE gels to PVDF-membranes
(Immobilon-P, Millipore 0.45 µm) in transfer buffer (for 1 l: 3.03 g Tris base, 14.4 g
glycine, 20% [v/v] ethanol, ddH2O) using a Biorad semi-dry system (24 V, 300 mA,
30 min) or a Biorad wet blot system (100 V, 1 h, 4 °C) (Fig. 3c). For immuno-
blotting with Phos-tag gels, gels were kept at 4 °C and washed successively for
10 min with transfer buffer containing 10 mM EDTA and transfer buffer con-
taining 0.1% (w/v) SDS, and transfer to PVDF-membranes (Immobilon-P, Milli-
pore, 0.45 µm) was done using a Biorad wet blot system (80 V, 120 min, 4 °C). After
transfer, membranes were blocked by incubation with blocking buffer for 1 h at
room temperature. Blocking buffer was 1X PBS (137 mM NaCl, 27 mM KCl,
81 mM Na2HPO4, 18 mM KH2PO4) containing 0.1% (v/v) Tween20 and 5% (w/v)
skimmed milk powder (for experiments shown in Fig. 3c) or TBST (20 mM 1M
Tris-HCl pH 7.5, 150 mM 5M NaCl, 0.1% [v/v] Tween20) containing 5% skimmed
milk powder (all other experiments). After blocking, membranes were incubated
with the primary antibody in blocking buffer for 1 h at room temperature or
overnight at 4 °C, followed by three washes in blocking buffer (5 min, room tem-
perature) and incubation with the secondary antibody in blocking buffer for 1 h at
room temperature. Membranes were washed three to four times with blocking
buffer and three times in 1X PBS (for experiments shown in Fig. 3c) before
addition of ECL detection reagent (KPL LumiGLO or LumiGLO Reserve, SeraCare
Life Sciences). Chemiluminescence was detected using a Fujifilm LAS-4000 Imager
(Fuji) with automatic exposure time determination or by exposure of membranes
to X-ray films (Fujifilm). Primary antibodies were used at the following dilutions:
α-MreB (1:20,000) (a gift from Régis Hallez), α-TacA (1:15,000)12, α-SpmX
(1:10,000)12, α-PleC (1:5000)28, α-CtrA (1:5000)29, M2 α-FLAG (1:10,000) (Sigma).
Secondary antibodies HRP-conjugated rabbit anti-mouse and swine anti-rabbit
(Dako Cytomation, DK) were used at a 1:10,000 dilution.
Microscopy and image analysis. Cultures were grown in PYE and imaged in
exponential phase (OD660 of 0.3–0.4) on 1% agarose PYE pads. Microscopy images
were acquired using softWoRx 6.0 (GE Healthcare) on a DeltaVision system (GE
Healthcare), equipped with a pco.edge sCMOS camera, and an UPlan FL N 100×/
1.30 oil objective (Olympus). DivJ-mCherry localization was analyzed using Fiji
software package30 with the MicrobeJ plugin31. Oufti32 was used to quantify cell
length and data were analyzed in Prism 7 (GraphPad) with statistical testing using
ordinary one-way ANOVA and Tukey’s multiple comparison test. SpmX-mCherry
localization and stalk formation (Supplementary Fig. 1) was analysed manually.
Time-lapse microscopy and image analysis. For Fig. 4 and Supplementary Fig. 7
spmX promoter activity during the cell cycle of single cells of C. crescentus wild type
and selected mutants was analyzed using PspmX-Dendra2 and time-lapse micro-
scopy. Strains were grown overnight in 5 ml PYE supplemented with appropriate
antibiotics in a roller drum at 30 °C. On the day of the experiment, these cultures
were diluted 50-fold in 5 ml PYE supplemented with 2.5 µg ml−1 oxytetracycline
and if appropriate with 0.1 mM IPTG and allowed to grow in a roller drum at 30 °C
until they reached an OD660 of 0.2. Cells were mounted on 1% PYE medium agar
pads containing appropriate supplements sealed with a double layer of gene frames
(Thermo Fisher Scientific; 1.7 × 2.8 cm) and subjected to time-lapse microscopy
using softWoRx 6.0 (GE Healthcare) on a DeltaVision system (GE Healthcare),
equipped with a pco.edge sCMOS camera, and an UPlan FL N 100×/1.30 oil
objective (Olympus) using 0.3 s exposure time for phase-contrast, FITC and TRITC
channels and a frame rate of 1 frame/15 min for different amounts of time.
For Fig. 4b, c, Supplementary Fig. 7, green Dendra2 was irreversibly
photoconverted to red in the latest detectable predivisional stage 15 min before the
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first visible cell separation and birth of the swarmer cell using 2 s UV light (DAPI
channel) leading to a conversion efficiency from green to red between 62–75%.
Image processing and analysis was done using the Fiji software package30. From
every predivisional cell and its offspring (swarmer and stalked cell) the total cell
fluorescence and cell area was manually measured for every time point over the
course of one cell cycle and if appropriate for up to three consecutive cell cycles and
the integrated density (mean intensity normalised to cell area) determined. In case
of time point 0 (predivisional cell after photoconversion), the mean intensity of the
predivisional was normalised to the area of the swarmer or stalked cell. Integrated
density values were then normalised for background fluorescence to obtain
normalised fluorescence values over the cell cycle, plotted as arbitrary units (A.U.)
in Supplementary Fig. 7.
In order to determine the fraction of cells with induced spmX promoter activity
in Fig. 5c, for individual cells the mean of all normalised fluorescence values over
one cell cycle was calculated. If the mean normalised fluorescence was above 150 A.
U., cells were scored as showing induced PspmX activity; if below 150 A.U. then
cells were scored as non-induced.
In Fig. 4c normalised fluorescence values over the cell cycle of each cell type
were set relative to the value of the late predivisional cell after photoconversion
(t0= 1). Green Dendra2 was irreversibly photoconverted to red only once in the
latest detectable predivisional stage 15 min before the first visible cell separation
and birth of the swarmer cell of generation 1. Image analysis was done as described
above. Normalised fluorescence values of each cell type over each of the three cell
cycles were set relative to the first late predivisional cell after photoconversion. The
slope of relative fluorescence was determined over the course of one cell cycle and
cells were scored as showing induced activity if the slope ≥0.19 or as not showing
activity if the slope ≤0.19. The fraction of cells with induced spmX promoter
activity was then calculated and plotted.
The ON kinetics of PspmX activity in Fig. 4b was determined as following:
Dendra2 was photoconverted once using 2 s UV light (DAPI channel) in the latest
detectable predivisional stage 15 min before the first visible cell separation and
birth of the swarmer cell. Cells were normalized and evaluated as above. The time
of the first visible increase of cell fluorescence in the swarmer cell (green line) and
the stalked cell (gray line) cells with slope ≥0.075 was plotted as fraction of cells
with induced spmX promoter activity over time. For inferred OFF kinetics (blue
dashed line), cells at different cell cycle stages were photoconverted once using 2 s
UV light (DAPI channel), normalized as above and the increase of fluorescence
within 15-min intervals was determined using the first time point after visible cell
separation as reference. Fraction of cells scored as having induced spmX promoter
activity over the cell cycle was plotted over time. Results were plotted using Prism 7
(GraphPad).
β-Galactosidase assays. For β-galactosidase assays strains harboring pAK502-
based lacZ reporter plasmids were grown in 2 ml PYE supplemented with chlor-
amphenicol and additional antibiotics as appropriate overnight at 30 °C in a drum
roller and diluted the next day 20-fold in 2 ml of the same medium, followed by
further incubation for an additional 4.5 h under the same conditions before sam-
pling. β-Galactosidase assays were performed according to Miller33. For β-
galactosidase assays strains harboring pRKlac290-based plasmids were grown
overnight in 5 ml PYE supplemented with the appropriate antibiotics in a roller
drum at 30 °C. On the day of the experiment, these cultures were diluted 20-fold in
5 ml PYE supplemented with appropriate antibiotics and allowed to grow in a
roller drum at 30 °C until they reached an OD660 of 0.3–0.54. 1.8 ml culture was
spun and the pellet resuspended in 1.8 ml Z-buffer (0.06 M Na2HPO4, 0.04M
NaH2PO4, 0.01 M KCl, 0.001 M MgSO4, 0.05 M β-mercaptoethanol) of which
0.8 ml were used for OD660 measurements and 1 ml transferred to a chloroform-
stable Eppendorf tube. Subsequently, 100 µl 0.1% SDS and 20 µl chloroform were
added. Samples were vortexed for 10 s and incubated at room temperature for
30–60 min. From the top aqueous layer of the mixture three times 200 µl (three
technical replicates) were transferred to a 96-well plate, 25 µl ONPG (4 mgml−1 in
Z-buffer) were added to each well and consumption of ONPG was followed at
405 nm using a BioTek Instruments EL800 plate reader (20 reads at the fastest
interval). β-galactosidase activity was calculated as the initial slope of the increase of
OD405 over time at a linear range and corrected for the OD660 and volume. Activities
were normalized to the activity of a wild-type strain that was included in all assays.
Flow cytometry. Cultures were inoculated from a fresh colony and strains were
grown in 2 ml PYE at 30 °C in a drum roller 20 h (stationary phase) or diluted back
20-fold in 2 ml of the same medium after overnight incubation, followed by
incubation for an additional 4.5 h (exponential phase). Rifampicin was added to
cultures at a final concentration of 25 µg ml−1 and cultures were incubated for 2 h
under the same conditions before cells were being fixed in cold 70% ethanol. Cells
were collected by centrifugation, resuspended in 0.5 ml FACS buffer (10 mM Tris-
HCl pH 7.5, 1 mM EDTA, 50 mM sodium citrate, 0.01% [v/v] TritonX-100)
containing 2.5 µl RNaseA solution (Sigma) and incubated at room temperature for
30 min, after which 50 µl were transferred to 1 ml FACS buffer containing 1.5 µl
YO-PRO-1 iodide (Thermo Fisher Scientific) and incubated for 2 h at room
temperature in the dark. Data were acquired using a FACS Canto II (BD Bios-
ciences) with >50,000 events recorded and analyzed with FlowJo software (FlowJo
LLC). The gating strategy is outlined in Supplementary Fig. 10.
Mass spectrometry-based proteome analysis. 109 C. crescentus cells grown in
PYE to exponential phase were collected, washed twice with phosphate buffer,
resuspended in 50 µl lysis buffer (1% sodium deoxycholate, 0.1 M ammoniumbi-
carbonate), reduced with 5 mM TCEP for 15 min at 95 °C and alkylated with 10
mM chloroacetamide for 30 min at 37 °C. Samples were digested with trypsin
(Promega) at 37 °C overnight (protein to trypsin ratio: 50:1) and desalted on C18
reversed phase spin columns according to the manufacturer’s instructions
(Microspin, Harvard Apparatus).
One microgram of peptides of each sample were subjected to LC-MS analysis
using a dual pressure LTQ-Orbitrap Elite mass spectrometer connected to an
electrospray ion source (both Thermo Fisher Scientific). Peptide separation was
carried out using an EASY nLC-1000 system (Thermo Fisher Scientific) equipped
with a RP-HPLC column (75 μm× 30 cm) packed in-house with C18 resin
(ReproSil-Pur C18–AQ, 1.9 μm resin; Dr Maisch GmbH, Ammerbuch-Entringen,
Germany) using a linear gradient from 95% solvent A (0.15% formic acid, 2%
acetonitrile) and 5% solvent B (98% acetonitrile, 0.15% formic acid) to 28% solvent
B over 75 min at a flow rate of 0.2 μl/min. The data acquisition mode was set to
obtain one high resolution MS scan in the FT part of the mass spectrometer at a
resolution of 240,000 full width at half-maximum (at m/z 400) followed by MS/MS
scans in the linear ion trap of the 20 most intense ions. The charged state screening
modus was enabled to exclude unassigned and singly charged ions and the dynamic
exclusion duration was set to 20 s. The ion accumulation time was set to 300 ms
(MS) and 50 ms (MS/MS). The collision energy was set to 35%, and one microscan
was acquired for each spectrum. For all LC-MS measurements, singly charged ions
and ions with unassigned charge state were excluded from triggering MS2 events.
To determine changes in protein expressions across samples, a MS1-based
label-free quantification was carried out. Therefore, the generated raw files were
imported into the Progenesis QI software (Nonlinear Dynamics, Version 2.0) and
analyzed using the default parameter settings. MS/MS-data were exported directly
from Progenesis QI in mgf format and searched against a decoy database of the
forward and reverse sequences of the predicted proteome from Caulobacter
crescentus (strain NA1000/CB15N) (Uniprot, download date: 08/09/2015, total of
(8234 entries) using MASCOT. The search criteria were set as following: full tryptic
specificity was required (cleavage after lysine or arginine residues); three missed
cleavages were allowed; carbamidomethylation (C) was set as fixed modification;
oxidation (M) as variable modification. The mass tolerance was set to 10 ppm for
precursor ions and to 0.6 Da for fragment ions. Results from the database search
were imported into Progenesis QI and the final peptide measurement list
containing the peak areas of all identified peptides, respectively, was exported. This
list was further processed and statically analyzed using our in-house developed
SafeQuant R script (SafeQuant, https://github.com/eahrne/SafeQuant 34). The
peptide and protein false discovery rate was set to 1% using the number of reverse
hits in the dataset. All quantitative analyses were performed in biological triplicates.
All raw data and results associated with the manuscript have been deposited to the
ProteomeXchange Consortium via the PRIDE35 partner repository with the dataset
identifier PXD012739.
Genetic selection for c-di-GMP-independent mutations in shkA. Six indepen-
dent colonies of strain AKS1 (CB15 rcdG0 ΔlacA::Ω ampG::pNPTStet-ampG)
harboring in addition plasmid pAK503-spmX were inoculated into 5 ml PYE
containing chloramphenicol (1 mg l−1) and oxytetracycline (10 mg l−1) and grown
overnight. For UV mutagenesis, 2 ml of each culture was distributed in six-well
plates and irradiated with 10,000 mJ UV light using a Stratalinker, after which 5 ml
PYE containing chloramphenicol (1 mg l−1) and oxytetracycline (10 mg l−1) were
added and cultures grown for 7 h at 30 °C with shaking. Five hundred microliters of
each culture were plated on PYE plates containing chloramphenicol (1 mg l−1),
oxytetracycline (10 mg l−1), and kanamycin (6.25 mg l−1) and plates incubated at
30 °C for 4 days. All colonies from one plate were pooled, diluted to an OD660 of
0.1 and grown for 7 h at 30 °C, and phage lysates were prepared for each inde-
pendent pool. Following transduction of strain AKS17 (CB15 rcdG0 ΔlacA::Ω
/pAK502-spmX) with individual pool lysates, cells were plated on PYE containing
chloramphenicol (1 mg/l), oxytetracycline (10 mg l−1), and X-Gal (40 mg l−1) and
incubated at 30 °C for 3 days. Blue colonies were once restreaked to confirm their
blue colony phenotype, followed by colony-PCR using primers 9765 and 9766 and
sequencing (Microsynth, Balgach, Switzerland) of the PCR product using primers
9765, 9766, 6011, and 6498.
Genetic screen for mutations abolishing spmX’-‘lacZ activity. Transposon
mutagenesis was performed by delivery of pSAM-Ec in strain UJ6168 carrying
pAK502-spmX by conjugation and cells were plated on PYE containing chlor-
amphenicol (1 mg l−1), kanamycin (50 mg l−1), nalidixic acid (20 mg l−1), and X-
Gal (40 mg l−1) and incubated at 30 °C for 3 days. White colonies were pooled in
5 ml PYE supplemented with appropriate antibiotics and grown overnight to
prepare φCR30 lysates. From this pool lysate transposon insertions were trans-
duced in a clean background (UJ6168/pAK502-spmX), followed by blue/white
screening as described above. Lysates were prepared from single white colonies and
mutations transduced in a NA1000 wild-type background. Transposon insertion
sites were mapped using a two-step semi-arbitrary PCR approach36. Primers 9058,
9003 and 9004 were used in the first PCR and primers 9058 and 9005 in the second
PCR. PCR products were sequenced (Microsynth, Balgach, Switzerland) with
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primer 9058. In one strain (AKS50), the transposon mapped within pleD at
position 2′695′825 of the NA1000 reference genome37.
Protein expression and purification. For isothermal titration calorimetry (ITC)
and in vitro phosphorylation experiments shown in Fig. 2, proteins were expressed
and purified as follows. E. coli Rosetta 2(DE3) cells were used to express proteins from
pET28a and pET32b expression plasmids. Cells were grown in LB-Miller supple-
mented with the appropriate antibiotics to an OD600 of 0.4–0.6, expression was then
induced with 0.5mM IPTG for 4 h at 30 °C. Proteins were purified on an ÄKTA-
purifier 10 system (GE Healthcare) using 1ml HisTrap HP columns (GE Healthcare)
followed by size exclusion chromatography (HiLoad 16/60 Superdex 200) using the
following buffers: lysis buffer (wash buffer supplemented with protease inhibitor,
DNase I [NEB]), wash buffer (20mM HEPES-KOH pH 8.0, 0.5M NaCl, 10% gly-
cerol, 20mM imidazole, 1 mM DTT), elution buffer (20mM HEPES-KOH pH 8.0,
0.5M NaCl, 10% glycerol, 500mM imidazole, 1 mM DTT), storage buffer (10mM
HEPES-KOH pH 8.0, 50mM KCl, 10% glycerol, 0.1mM EDTA, 1mM DTT). MgCl2
was added to reaction mixtures immediately prior to experiments to a final con-
centration of 5 mM. For all other experiments using purified ShkA, mutant variants
thereof and ShkAREC1, except NMR experiments (see below), proteins were expressed
in E. coli BL21(DE3) grown in LB-Miller at 37 °C in 500-ml cultures, with IPTG
induction (1mM) at an OD600 of 0.5–0.8 followed by incubation for 4 h. Cells were
harvested by centrifugation (5000 × g, 20 min, 4 °C), washed once with 20ml of 1X
PBS, flash-frozen in liquid N2, and stored at −80 °C until purification. For purifica-
tion, the pellet was resuspended in 8ml of buffer A (2X PBS containing 500mM
NaCl, 10mM imidazole and 2mM β-mercaptoethanol) supplemented with DNaseI
(AppliChem) and Complete Protease inhibitor (Roche). After one passage through a
French press cell, the suspension was ultra-centrifuged (100,000 × g, 30 min, 4 °C) and
the supernatant was mixed with 800 µl of Ni-NTA slurry, prewashed with buffer A,
and incubated for 1–2 h on a rotary wheel at 4 °C. Ni-NTA agarose was loaded on a
polypropylene column and washed with at least 50ml of buffer A, after which the
protein was eluted with 2.5ml of buffer A containing 500mM imidazole. The eluate
was immediately loaded on a PD-10 column pre-equilibrated with kinase buffer
(10mM HEPES-KOH pH 8.0, 50mM KCl, 10% glycerol, 0.1 mM EDTA, 5mM
MgCl2, 5 mM β-mercaptoethanol). The protein was then eluted with 3.5ml of kinase
buffer and stored at 4 °C until further use, usually no longer than one week. Uniformly
[13C, 15N]-labeled protein for NMR studies was prepared by growing BL21(DE3) cells
harboring pET28a-shkAREC1 in 1 l M9 minimal medium, with 1 g 15NH4Cl and 2 g
[U-13C] glucose per liter medium, at 37 °C. Expression was induced at an OD600 of 0.8
with 1mM IPTG and cells were harvested 4 h post induction. ShkAREC1 was purified
using Ni-NTA slurry as described above, followed by size exclusion chromatography
(HiLoad 16/60 Superdex 200) on a ÄKTApurifier 10 system (GE Healthcare) with
NMR buffer (25mM Tris pH 7.2 with 50mM KCl, 2mM MgSO4) and concentration
of the sample using Vivaspin6 5 kDa MWCO concentrators (Sartorius).
Isothermal titration calorimetry (ITC). ITC binding assays were performed with
a VP-ITC isothermal titration calorimeter (MicroCal). Concentrations were 12 µM
ShkA in the cell and 130 µM cdG in the syringe. ITC Buffer: 10 mM HEPES-KOH
pH 8.0, 100 mM NaCl, 10% glycerol, 1 mM DTT. After a first injection of 3 µl, 10 µl
was injected at 29 time points. Data analysis was performed with MicroCal
(ORIGIN) and fitted with the One binding site model of ORIGIN.
In vitro phosphorylation assays. Kinase assays were adapted from9. Reactions
were performed in kinase buffer supplemented with 433 µM ATP and 5-20 µCi
[γ32P]-ATP (3000 Ci/mmol, Hartmann Analytic) at room temperature if not
otherwise mentioned. Additional nucleotides were added as indicated in the figures
or figure legends. Kinase reactions contained 5 µM ShkA and were run for 3.5 min
at room temperature if not otherwise mentioned and stopped by addition of 5X
SDS sample buffer and stored on ice, then run on 12.5% SDS-PAGE or precast
Mini-Protean TGX (Biorad) gels. Wet gels were exposed to a phosphor screen for
0.5–3 h and then scanned using a Typhoon FLA 7000 imaging system (GE
Healthcare), after which gels were stained with Coomassie Brilliant Blue.
C-di-GMP UV-crosslinking assays. 32P-labeled c-di-GMP was prepared by
incubation of 250 µCi [α32P]-GTP (3000 Ci mmol−1, Hartmann Analytic) in 200 µl
DgcZ reaction buffer (50 mM Tris-HCl pH 7.5, 50 mM NaCl, 5 mM MgCl2) with
2 µM purified DgcZ for 24 h at 30 °C. DgcZ (YdeH) was purified as described
previously38. The reaction was stopped by boiling and, after centrifugation (1 min,
16,000 × g), the supernatant containing radiolabeled c-di-GMP was removed and
stored at −20 °C. Non-radio-labeled c-di-GMP was prepared as described pre-
viously38 with the following modifications. 5% (v/v) methanol and 5 mM tetra-
ethylammonium bromide were added to the c-di-GMP reaction and the mixture
was loaded on a Luna 10 µM C18(2) 100 Å, 100 × 21.2 mm column (Phenomenex).
GTP was removed by isocratic elution in TEAB buffer (5 mM tetraethylammonium
bromide, 5% [v/v] methanol) over three column volumes (CV), after which c-di-
GMP was eluted with a linear gradient from 0–20% ethanol in TEAB buffer over
four CV. c-di-GMP was lyophilized overnight, resuspended in ddH2O at a con-
centration of 10 mM and aliquoted. Aliquots were lyophilized and stored at
−20 °C. ddH2O was added to aliquots to give a 10 mM working stock, the con-
centration of which was verified by measuring absorbance at 253 nm. A 80mM
stock solutions of hot c-di-GMP was prepared by mixing 10–20 µCi 32P-labeled c-
di-GMP with 4 µl 1 mM cold c-di-GMP in a final volume of 50 µl. More dilute
stock solutions were prepared by mixing with ddH2O. UV-crosslinking reactions
(16 µl) contained 4 µl of hot c-di-GMP to give the indicated final concentrations
and 0.5 µM ShkA, ShkA mutant variants or ShkAREC1 in kinase buffer, and were
incubated at room temperature for 45 min before UV crosslinking at 4 °C, 254 nm,
2 min on a Caprotec Protein Detector. For competition experiments, reactions
contained a 50-fold molar excess of cold c-di-GMP over hot c-di-GMP added from
a 10mM stock. Samples were mixed with 5X SDS sample buffer, boiled for 10 min
and run on 12.5% SDS-PAGE or precast Mini-Protean TGX (Biorad) gels. Gels
were stained with Coomassie Brilliant Blue, dried and exposed to a phosphor
screen that was scanned using a Typhoon FLA 7000 imaging system (GE
Healthcare). Bands of autoradiographs were quantified using Fiji and normalized
to wild-type ShkA, which was run in parallel to mutant variants or ShkAREC1 on
the same gel for each experiment. Experiments were repeated twice and values
represent means and standard deviations. Binding curves were fitted to a
“Binding—saturation, One site—Total” model using Prism 7 (GraphPad).
Nuclear magnetic resonance (NMR) spectroscopy. All NMR spectra were
recorded at 25 °C on a Bruker Avance-700 spectrometer equipped with a cryo-
genically cooled triple-resonance probe. ShkAREC1 protein samples were prepared
in 25 mM Tris pH 7.2 with 50 mM KCl and 2 mM MgSO4 in 95%/5% H2O/D2O.
For the sequence-specific backbone resonance assignment of 950 μM [U-15N, 13C]-
ShkAREC1, the following NMR experiments were recorded: 2D [15N,1H]-TROSY,
3D HNCA and 3D HNCACB. For the c-di-GMP binding experiments a series of
2D [15N,1H]-TROSY spectra of 200 μM [U-15N]-ShkAREC1 were recorded
with c-di-GMP concentrations of 0 μM, 20 μM, 50 μM, 100 μM, 150 μM,
200 μM and 400 μM. CSPs (Δδ(HN)) of amide moieties were calculated as
Δδ HNð Þ ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
0:5  Δδ 1Hð Þ2þ 0:2  Δδ 15Nð Þð Þ2 
q
, where Δδ 1Hð Þ and Δδ 15Nð Þ,
are the amide proton and amide nitrogen chemical shift differences to the reference
spectrum, respectively. Combined secondary chemical shifts of Cα and Cβ were
calculated relative to the random-coil values of Kjaergaard and Poulson39.
C-di-GMP extraction and quantifications. Strains AKS371 and AKS412 were
grown in 2 ml PYE overnight, diluted 40-fold the next day in 20 ml PYE and grown
for 6 h until reaching an OD660 of ~0.35. 14 ml were spun down (11,000 × g, 5 min,
4 °C), the pellet was washed once in 1 ml ddH2O (16,000 × g, 2 min, 4 °C) and
snap-frozen in liquid nitrogen. Metabolites were extracted by resuspending the
pellet in 300 μl ice-cold extraction solvent (40% [v/v] acetonitrile, 40% [v/v]
methanol, 20% [v/v] ddH2O) and incubation at 95 °C for 10 min. Extractions were
repeated on the pellet twice with 200 μl extraction solvent and the pooled extracts
(700 μl) were stored overnight at −80 °C. Remaining debris was removed by
centrifugation (16,000 × g, 10 min, 4 °C), the supernatant was transferred to a fresh
microcentrifuge tube and solvent was removed using a Speedvac. LC-MS-based c-
di-GMP quantification was performed by the Zentrale Forschungseinrichtung
(ZFA) Metabolomics, Medizinische Hochschule Hannover, Germany, and cellular
concentrations were calculated as described before11. Experiments were performed
in biological triplicates and values given are means and standard deviations.
Sequence alignments, structure prediction, and modeling. The C. crescentus
ShkA sequence was blasted against the nonredundant protein sequences (nr)
database using default settings and the first 500 hits were aligned in Geneious using
the Geneious Alignment algorithm with default settings (Supplementary Data 1).
The alignment was manually checked for the presence of the DDR motif in the
REC1-REC2 linker and the sequences that harbored this motif (see Fig. S3A) were
realigned as described above. This alignment was used to create sequence logos
using WebLogo340, construct a phylogenetic tree using Geneious Tree Builder with
default settings and calculate conservation scores using the ConSurf server41. Four
proteins of the original blast set that do not contain the DDR motif were included
in the phylogenetic tree for comparison. Secondary structure prediction for E. coli
BarAPRD (residues 532–655) was performed with HHPred42 and the ShkAREC1-
BarAPDR alignment was generated in Geneious as described above. The ShkAREC1-
3GRC alignment was generated using HHPred. The ShkAREC1 structure was
modeled using the SWISS-MODEL workspace43 with PDB entry 3GRC as the
template. CSPs and conservation scores mapped onto the ShkAREC1 model were
visualized using MacPyMol (PyMOL v1.7.6.6, Schrödinger LLC).
Data availability
The sequence-specific backbone resonance assignment of the ShkARec1 domain has been
submitted to the Biological Magnetic Resonance Data Bank under the following
accession code: 27768 [http://www.bmrb.wisc.edu/data_library/summary/index.php?
bmrbId=27768]. All proteomics raw data and results associated with the manuscript
have been deposited to the ProteomeXchange Consortium via the PRIDE partner
repository with the dataset identifier PXD012739 [http://www.ebi.ac.uk/pride/archive/
projects/PXD012739]. The source data underlying Figs. 1d–h, 2c–i, 3c, e–h and 5b–f and
Supplementary Figs. 1b, 2a, c–e, 4b, h and 8a are provided as Source Data files. The
source data underlying Fig. 4c and Supplementary Fig. 7c are deposited on Zenodo
[https://doi.org/10.5281/zenodo.3574247].
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